Neurocrine Bioscience buy JPMorgan Chase & Co.
Start price
03.11.25
/
50%
€123.25
Target price
03.11.26
€155.28
Performance (%)
8.24%
Price
09.12.25
€133.40
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 8.24%. This prediction currently runs until 03.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 2.576% | 2.576% |
| iShares Core DAX® | 1.659% | 1.586% |
| iShares Nasdaq 100 | 0.381% | 1.900% |
| iShares Nikkei 225® | 2.102% | -1.377% |
| iShares S&P 500 | 0.221% | 1.258% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at JPMorgan Chase & Co. from $171.00 to $179.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.70
26.03.25
26.03.25
€170.49
26.03.26
26.03.26
26.21%
09.12.25
09.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€132.10
07.08.24
07.08.24
€165.67
07.08.25
07.08.25
-18.89%
08.08.25
08.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.00
10.07.24
10.07.24
€159.75
10.07.25
10.07.25
-15.30%
11.07.25
11.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€128.85
20.03.24
20.03.24
€145.64
20.03.25
20.03.25
-21.07%
21.03.25
21.03.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.00
23.02.24
23.02.24
€136.69
23.02.25
23.02.25
-7.50%
24.02.25
24.02.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€124.83
13.09.24
13.09.24
-0.05%
14.09.24
14.09.24